Post hoc analysis
METASTASIS
We performed a post hoc analysis to see whether the efficacy of apatinib plus capecitabine was affected by patient characteristics and previous treatment. Patients with multiple organ involvement exhibited a much lower ORR than those with metastasis in a single organ (54.5% vs. 22.6%, 